Clinical Characteristics of Toxicities of Immune Checkpoint Inhibitors and Their Impact on Efficacy in Solid Cancers: An Analysis of Real-World Data in Moroccan Patients We designed a point-of-care ...
The firm hopes to exploit its first-mover advantage in the OTC space following de novo clearance for an at-home PCR test to detect sexually transmitted infections.
The In Vitro Diagnostics (IVD) Quality Control Market is driven by the increasing prevalence of chronic and infectious diseases, growing adoption of point-of-care testing, and technological ...
(MENAFN- GlobeNewsWire - Nasdaq) The EMEA point-of-care diagnostics market presents opportunities through rapid diagnostic innovations, especially in infectious disease detection and cardiovascular ...
Dublin, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The "Microfluidics Market - Forecasts from 2025 to 2030" has been added to ResearchAndMarkets.com's offering. The global microfluidics market is poised for ...
Scientists at the Department of Applied Physics II of the University of Malaga have participated in the design of a new technology that controls fluids and particles in three dimensions through ...
Tampa, FL, USA – September 25, 2025 – With global attention shifting away from mpox after recent declines in case counts, the Global Virus Network (GVN) is warning against complacency and urges ...
Quest Diagnostics Inc. Annual cash flow by MarketWatch. View DGX net cash flow, operating cash flow, operating expenses and cash dividends.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback